RESULTS
At the beginning of the research, 34 patients were included in the study based on the determined inclusion criteria, but due to the patient loss to follow up, one month after the injection for a return visit, as one of the exclusion criteria, the information related to 20 patients were evaluated, in the end. In terms of gender, 6 patients (30%) were male and 14 patients (70%) were female. The gender distribution of patients can be seen in Figure 